In GBM, miRNA-155HG was also correlated with poor prognosis, malignancy, EMT and tumor progression; these effects were the result of the modulation of miRNA-155 expression and its downstream target genes, such as protocadherin 7 and 9, both acting as tumor suppressors (Wu et al., 2017). This evidence concerns the gene PCDH7 and neoplasm.